<DOC>
	<DOCNO>NCT00950521</DOCNO>
	<brief_summary>The objective study determine efficacy brain transplant CD34+ stem cell obtain peripheral blood patient treatment chronic stroke patient .</brief_summary>
	<brief_title>Efficacy Study CD34 Stem Cell Chronic Stroke Patients</brief_title>
	<detailed_description>30 patient divide 2 group , one treatment group one control group.Treatment group implant peripheral blood stem cell receive convention stroke therapy , control group receive convention stroke therapy . We expect transplantation peripheral blood CD34+ cell potential significant benefit neurological recovery . In previous phase I clinical trial , show transplantation CD34+ cell obtain peripheral blood chronic stroke patient safe beneficial neurological recovery . We expect trial prove efficacy treatment method .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<criteria>aged 3570 chronic stroke adult patient , stroke history 6 month , less 60 months， stable hemiplegia condition , NIHSS ( NIH Stroke Scale ) score 920. patient age less 35 70 , hemorrhage stroke MRI show occlusion middle cerebral artery territory，NIHSS range 920 , pregnant woman , impair liver function , abnormal blood coagulation , AIDS , combine tumor special condition .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Stem Cell</keyword>
	<keyword>Cell Therapy</keyword>
	<keyword>CD34 Stem cell</keyword>
	<keyword>Peripheral blood Stem cell</keyword>
</DOC>